January 30, 2019
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Read More
January 30, 2019
Immunogenicity and Safety Study of GSK Biologicals’ GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
Read More
January 30, 2019
Immunogenicity and Safety Study of GSK Biologicals’ GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
Read More
January 30, 2019
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine Administered as a Booster Dose
Read More
January 30, 2019
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine Administered as a Booster Dose
Read More
January 30, 2019
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer’s Disease Dementia
Read More
January 30, 2019
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Read More
December 10, 2018
Anagrelide Retard vs. Placebo: Efficacy and Safety in “At-risk” Patients With Essential Thrombocythaemia
Read More
December 10, 2018
Anagrelide Retard in Essential Thrombocythemia
Read More
December 10, 2018
Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera
Read More
December 10, 2018
AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
Read More
December 10, 2018
Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients
Read More
Load More
X